AptaBio Therapeutics Inc. (293780.KQ)

KRW 7200.0

(1.27%)

Long Term Debt Summary of AptaBio Therapeutics Inc.

  • AptaBio Therapeutics Inc.'s latest annual long term debt in 2023 was 13.56 Billion KRW , up 5194.27% from previous year.
  • AptaBio Therapeutics Inc.'s latest quarterly long term debt in 2024 Q2 was 15.43 Billion KRW , up 6.66% from previous quarter.
  • AptaBio Therapeutics Inc. reported annual long term debt of 256.3 Million KRW in 2022, up 447.97% from previous year.
  • AptaBio Therapeutics Inc. reported annual long term debt of 46.77 Million KRW in 2021, up 33.89% from previous year.
  • AptaBio Therapeutics Inc. reported quarterly long term debt of 14.47 Billion KRW for 2024 Q1, up 6.66% from previous quarter.
  • AptaBio Therapeutics Inc. reported quarterly long term debt of 16.6 Billion KRW for 2023 Q3, up 5967.48% from previous quarter.

Annual Long Term Debt Chart of AptaBio Therapeutics Inc. (2023 - 2016)

Historical Annual Long Term Debt of AptaBio Therapeutics Inc. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 13.56 Billion KRW 5194.27%
2022 256.3 Million KRW 447.97%
2021 46.77 Million KRW 33.89%
2020 34.93 Million KRW 0.0%
2019 - KRW 0.0%
2018 - KRW 0.0%
2017 - KRW 0.0%
2016 - KRW 0.0%

Peer Long Term Debt Comparison of AptaBio Therapeutics Inc.

Name Long Term Debt Long Term Debt Difference
HLB Pharmaceutical Co., Ltd 988.75 Million KRW -1272.376%
CMG Pharmaceutical Co., Ltd. 19.06 Billion KRW 28.822%
Celltrion Pharm, Inc. 4.33 Billion KRW -213.143%
Huons Global Co., Ltd. 66.94 Billion KRW 79.73%
DongKook Pharmaceutical Co., Ltd. 18.74 Billion KRW 27.629%
Enzychem Lifesciences Corporation 1.02 Billion KRW -1223.849%
Humedix Co., Ltd. 1.75 Billion KRW -673.043%
Boditech Med Inc. 2.09 Billion KRW -546.183%
EuBiologics Co., Ltd. 2.8 Billion KRW -384.623%
FutureChem Co.,Ltd 2.61 Billion KRW -417.958%
Huons Co., Ltd. 58.35 Billion KRW 76.745%
BNC Korea Co., Ltd. 301.69 Million KRW -4397.81%